These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 867322)
1. [Complications and risks of treatment with anticoagulants and drugs affecting platelet function (author's transl)]. Frick P Ther Umsch; 1977 May; 34(5):379-83. PubMed ID: 867322 [No Abstract] [Full Text] [Related]
5. Bleeding complications in the patient with cardiac disease following thrombolytic and anticoagulant therapies. Dunn SM; Senerchia CB Crit Care Nurs Clin North Am; 1993 Sep; 5(3):511-23. PubMed ID: 8217046 [TBL] [Abstract][Full Text] [Related]
6. [Complications of anticoagulant and thrombolytic therapy]. Sparacia A; Di Chiara A Minerva Anestesiol; 1981 Mar; 47(3):115-22. PubMed ID: 6454086 [No Abstract] [Full Text] [Related]
7. Pre-operative management of patients on drugs affecting blood coagulation. Dabrowski P; Orlicz-Szczesna G Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):278-81. PubMed ID: 16145996 [TBL] [Abstract][Full Text] [Related]
8. [Problems of dosage and side-effects of anticoagulants and fibrinolytics (internal medicine, surgery)]. Goossens N Int J Clin Pharmacol; 1972 Jun; 6(2):188-95. PubMed ID: 4638974 [No Abstract] [Full Text] [Related]
10. Real risks of two common drugs. Johns Hopkins Med Lett Health After 50; 1999 May; 11(3):3. PubMed ID: 10232088 [No Abstract] [Full Text] [Related]
11. [Treatment of the first episode of pulmonary embolism in the hospital. Anticoagulants, anti-platelet aggregation drugs and thrombolysis stimulants]. Moriau M; Lavenne-Pardonge E; Col-De Beys C; Jaumin P; el Gariani A; Rubay J; Goenen M Acta Chir Belg; 1986; 86(2):97-105. PubMed ID: 3716728 [TBL] [Abstract][Full Text] [Related]
12. Preoperative stop or continue? New antithrombotic and anticoagulants. Ickx BE Acta Anaesthesiol Belg; 2001; 52(4):385-93. PubMed ID: 11799571 [No Abstract] [Full Text] [Related]
13. [Endoscopy in patients receiving anticoagulation or antiplatelet therapy]. Kjeldsen J; Pless T; Meisner S; Bytzer P Ugeskr Laeger; 2009 Apr; 171(17):1384-6. PubMed ID: 19413934 [TBL] [Abstract][Full Text] [Related]
18. [Anticoagulants and platelet active drugs in arterial occlusive disease (author's transl)]. Bollinger A Ther Umsch; 1980 Feb; 37(2):128-31. PubMed ID: 7385080 [No Abstract] [Full Text] [Related]
19. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer]. Mooe T Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861 [No Abstract] [Full Text] [Related]
20. [Platelet aggregation increase. An unexpected result in fibrinolytic therapy]. Griguer P Ann Cardiol Angeiol (Paris); 1973; 22(3):223-30. PubMed ID: 4731540 [No Abstract] [Full Text] [Related] [Next] [New Search]